Four Tips for Improved Digital Analytics in Pharma Marketing
With the evolution of digital measurement, we can track and measure any online campaign at a very granular level. With marketing budgets shrinking, this brings increased pressure for brand teams to...
Market Access Week in Review: September 22, 2016
NCQA Releases Annual Review of US Health Plans The National Committee for Quality Assurance (NCQA), on September 21, released its 2016–2017 ratings, evaluating 1,012 health plans across the nation....
Notes from the Conference Hall: DRG’s Take on Highlights from ECTRIMS 2016
From September 14th-17th, over 9,000 clinicians, scientists, and industry professionals—another record—convened in London for the 32nd Annual Meeting of the European Committee for Treatment and...
Digital News Roundup
Quantified Selfers got a shock as a major study of the effects of fitness trackers found that those who used them lost less weight than those that did not. Researchers studied 500 young and overweight...
Maximize the utility of data assets with cross-functional commercial data strategy
Healthcare data is more accessible today than ever before. By its very nature “big” data provides profound insights into the most complex business challenges. Collection and interpretation of all...
Enterprise Solutions: Risk of Rain
The divestiture of a market leader in any segment is unsettling to all parties. End users begin to question the efficacy of the company’s product, while competitors may question the health of the...
Covariate effects in network meta-analysis
Network meta-analysis (NMA) is becoming increasingly important for decision makers to assess the comparative efficacy and safety of interventions and is integral to health technology assessment (HTA...
Telestroke programs proving effective
An increasing number of hospitals and health systems are discovering the benefits of utilizing telemedicine to improve their time of treatment for stroke victims. According to a study published in the...
Formulary exclusions set up contentious environment for pharma companies
In an aggressive move to counteract the financial impact of expensive medications, CVS Health has excluded 154 products from its standard formulary in 2017, up from 124 in 2016. In the hotly debated...
Success Drivers in the Commercialization of Digitally Enabled Medical Products
The need for personalized digital data is rapidly increasing and informing the development of technologies that target some of the biggest challenges in effective healthcare delivery. Our eBook...
Unmet Need
Assess the unmet need Opportunity analysis Target product profiles Access the information you need at your fingertips to act on unmet needs
How ACOs are Winning (and Losing) at the Value-based Game
Narrow networks, the creation of smaller provider networks that was once standard in the HMO era, have returned to prominence as U.S. payers seek to better rein in cost and control physician behavior.
Emerging Therapies
New products can change markets. Are they changing yours? Learn what makes launches take off Why do some launches succeed while others fail?
What the Data Has to Show: How Shifting Procedural site of Service Affects Competitive Strategy in the Orthopedic Device Industry
Narrow networks, the creation of smaller provider networks that was once standard in the HMO era, have returned to prominence as U.S. payers seek to better rein in cost and control physician behavior.
Current Treatment
The landscape of medical treatment is shifting! Stay up to date with current treatment Get your bearings Take a reading Focus of treatment practices
Clinical Trial Recruitment
Narrow networks, the creation of smaller provider networks that was once standard in the HMO era, have returned to prominence as U.S. payers seek to better rein in cost and control physician behavior.
Access & Reimbursement Mini Ebook
Leave the Barriers behind! Identify the access and reimbursement barriers and learn to work with them In-depth insight regarding the impact of payer policy on physician prescribing behavior Expand...
Narrow Networks: Impact on US Market Access
Narrow networks, the creation of smaller provider networks that was once standard in the HMO era, have returned to prominence as U.S. payers seek to better rein in cost and control physician behavior.
How Social Intelligence Can Drive Value for Life Science Companies
While organizations once used social listening as an isolated tactic, the industry has matured to pursue social intelligence to support decisions across the enterprise and transform customer...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
